Yangjin
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients (NCT05914857) | Yangjin | 2023-12-20 |
Track Yangjin automatically
Every clearance here is in the API, with alerts when new ones post.